# Provider Clinical Summary (PROVIDER-ONLY)

_Decision-support summary. Not a diagnosis, treatment recommendation, or dosing guidance._

**Patient:** Aisha Johnson (DEMO-006)
**Status:** active · **Risk level:** Moderate Review Priority
**Latest assessment:** 2026-06-14T00:42:47.178245+00:00 · **Last follow-up:** 2026-03-11T09:00:00+00:00

## Clinical snapshot
- Primary phenotype: metabolic_dysfunction
- Secondary phenotype: dysautonomia
- Recovery stage (derived): improving — Clinical improvement score 62 (56–69 vs baseline).
- Confidence: 29 (low)
- Top contributors: Blood sugar instability, Sugar cravings, Unexplained weight gain, Cold intolerance, Temperature dysregulation

## Co-infection pattern scores
- bartonella: 0
- babesia: 29
- ebv: 0
- mold_cirs: 0
- mcas: 0

## Lab system scores
- inflammatory: 0
- immune: 0
- mitochondrial: 0
- hormonal: 0
- metabolic: 77
- nutritional: 6
- detoxification: 0
- neuroinflammatory: 0
- connective_tissue: 5
- Abnormal: fasting glucose (high), fasting insulin (high), hba1c (high), triglycerides (high), hdl (low), ldl (high), vitamin d (low)
- Missing: 39 marker(s)

## Safety review
- Overall: 26 (Moderate Review Priority)
- Missing safety info: current_medication_list_confirmed, pregnancy_status_confirmed, infection_status_confirmed

## Outcomes
- Clinical improvement score: 62
- Functional improvement score: 64

## Provider review
- Status: reviewed
- Notes: Insulin-resistant + dysautonomic features. Metabolic + cardiac monitoring; engine concurs on metabolic concern.

_Generated decision-support summary — physician review required. Source documents remain the source of truth._